Premier Path Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Premier Path Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$311K	Buy	554 +42	+8%	+$26.9K	0.04%	340
2025 Q4	$346K	Buy	512 +72	+16%	+$49K	0.04%	307
2025 Q3	$281K	Buy	440 +43	+11%	+$26.1K	0.04%	341
2025 Q2	$213K	Buy	+397	New	+$190K	0.03%	373
2024 Q4	–	Sell	-530	Closed	-$268K	–	378
2024 Q3	$268K	Sell	530 -116	-18%	-$56.4K	0.04%	321
2024 Q2	$315K	Buy	646 +80	+14%	+$40.2K	0.05%	284
2024 Q1	$307K	Sell	566 -6	-1%	-$3.28K	0.06%	271
2023 Q4	$317K	Buy	+572	New	+$269K	0.07%	246

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Premier Path Wealth Partners's IDXX Position: Q1 2026 in Review

Premier Path Wealth Partners increased its Idexx Laboratories (IDXX) stake by 8.2% in Q1 2026, buying an estimated $26.9K and bringing the position to 554 shares worth $311K. The position accounts for 0.04% of the portfolio, ranked #340.

Premier Path Wealth Partners first reported a position in IDXX in Q4 2023 and has held it in 8 quarters since. The position peaked at $346K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Premier Path Wealth Partners held 554 shares of Idexx Laboratories worth $311K as of Q1 2026.
Premier Path Wealth Partners bought 42 Idexx Laboratories shares in Q1 2026, an estimated $26.9K.
Idexx Laboratories made up 0.04% of Premier Path Wealth Partners's portfolio in Q1 2026, its #340 holding.
Premier Path Wealth Partners first reported a position in Idexx Laboratories in Q4 2023 and has held it in 8 quarters since.
Premier Path Wealth Partners's Idexx Laboratories position peaked at $346K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Premier Path Wealth Partners's 13F filing for Q1 2026, filed 23 Apr 2026.